Newest Cancer Treatments Drugs And Technology
Newest Cancer Treatments, Drugs And Technology
After some “pretty nasty” , Skinner, 60, of Larchmont, N.Y., became part of a clinical trial for pembrolizumab, marketed by Merck as Keytruda. The drug helps the body’s immune system fight the disease. Skinner started infusion treatments in April 2014. In July her surgeon took another biopsy. “He said, ‘If somebody hadn’t told me you had cancer, I never would have known,’ ” she notes. The tumor was gone. The Food and Drug Administration (FDA) has since approved further uses of Keytruda, such as for patients with a genetic mutation called mismatch repair deficiency. The drug continues to be tested for use by patients without the mutation. It is approved for some head and neck, lung, bladder and metastatic melanoma cancers, as well as Hodgkin lymphoma. During clinical trials, the medication was famously used to treat former President , who two years ago announced he had cancer in his brain and liver and said his fate was “in the hands of God, whom I worship.” Four months later, his cancer was gone. Skinner has seen similar results. She’s back at work and makes a point of swimming and playing tennis. “I’m running around like a maniac. I’m out gardening right now,” she says. “I know what a gift is, and I know the gift of life." —Mindy Fetterman Craig Cutler The DigniCap could help nearly 800,000 Americans avoid chemo-related hair loss.
Medical Breakthroughs Cancer
Pioneering drugs products and technologies provide an array of fresh possibilities
Pioneering drugs that remedy once-intractable diseases; clever products that make everyday living easier for people with injury or illness; innovative technologies that provide relief at a touch of a button — by all measures, 2017 has been a year of astounding health care advancements. Here are some of the ways medical trailblazers and researchers are creating fresh possibilities for you and your family. AARP Membership: PHOTOGRAPH BY BRIAN DOBEN: MAKE-UP: DOMINIC SANTIAGO/ROBERT MOULTON A clinical trial helped Adrienne Skinner to fight her stage 4 cancer.New Hope At Stage 4 br
Adrienne Skinner awoke from surgery to stunning news. “I came to, and he told me we couldn’t do it,” Skinner says of her surgeon, who had planned to remove a tumor from the end of her bile duct. “He said, ‘Cancer has invaded your liver. It’s stage 4. It’s systemic.’ ” She was diagnosed with ampullary cancer, a form so rare that no standard treatments existed. Until now.After some “pretty nasty” , Skinner, 60, of Larchmont, N.Y., became part of a clinical trial for pembrolizumab, marketed by Merck as Keytruda. The drug helps the body’s immune system fight the disease. Skinner started infusion treatments in April 2014. In July her surgeon took another biopsy. “He said, ‘If somebody hadn’t told me you had cancer, I never would have known,’ ” she notes. The tumor was gone. The Food and Drug Administration (FDA) has since approved further uses of Keytruda, such as for patients with a genetic mutation called mismatch repair deficiency. The drug continues to be tested for use by patients without the mutation. It is approved for some head and neck, lung, bladder and metastatic melanoma cancers, as well as Hodgkin lymphoma. During clinical trials, the medication was famously used to treat former President , who two years ago announced he had cancer in his brain and liver and said his fate was “in the hands of God, whom I worship.” Four months later, his cancer was gone. Skinner has seen similar results. She’s back at work and makes a point of swimming and playing tennis. “I’m running around like a maniac. I’m out gardening right now,” she says. “I know what a gift is, and I know the gift of life." —Mindy Fetterman Craig Cutler The DigniCap could help nearly 800,000 Americans avoid chemo-related hair loss.